Clinical Pharmacy

Dan Kabella, PhD

Postdoctoral Scholar
Clinical Pharmacy

Danielle Kabella, PhD received a doctorate in Human and Social Dimension of Science and Technology at Arizona State University's School for the Future of Innovation. Their doctoral research offers an ethnographic study that makes visible alternative strategies Chicanx communities use to articulate place-based drug recovery futures in New Mexico. They have co-developed and implemented ways of connecting their scholarship to broader and diverse audiences.

Candy Tsourounis, PharmD

Professor
Clinical Pharmacy

Dr. Candy Tsourounis is Professor of Clinical Pharmacy in the Department of Clinical Pharmacy in the School of Pharmacy at the University of California San Francisco. Dr. Tsourounis is involved in providing evidence-based reviews of recently approved prescription medications and performing medication utilization analyses in the Department's Medication Outcomes Center.

Lisa Kroon, PharmD

Professor
Clinical Pharmacy

Dr. Lisa Kroon is a Professor of Clinical Pharmacy in the Department of Clinical Pharmacy in the School of Pharmacy at the University of California in San Francisco. She holds an executive pharmacy leadership role at UCSF Health since 2020, where she was appointed the Assistant Chief Pharmacy Officer for Clinical Innovation, Education, and Research for the Pharmacy Enterprise, where she oversees ambulatory pharmacy practice. Dr.

Robin Corelli, PharmD

Vice Dean & Professor
Clinical Pharmacy

Primary interest in tobacco cessation education and training. Dr. Corelli has co-coordinated, with other Tobacco Center members (Drs. Hudmon and Kroon), a comprehensive tobacco cessation training program, Rx for Change: Clinician-Assisted Tobacco Cessation, for students in the health professions.

Dorie Apollonio, PhD, MPP

Professor
Clinical Pharmacy
Dr. Dorie Apollonio is a Professor of health policy in the Department of Clinical Pharmacy at the University of California, San Francisco focusing on tobacco control and policy making. Her research considers the role of scientific evidence and interest group lobbying in decision making on public health. This work uses multiple data sources including internal industry documents, campaign finance reports, administrative datasets, and interviews, and relies on both qualitative and quantitative methods to identify how policy affecting public health is made.